Alternatives to Ozari Health

Both prices came down since our last check: read live on 2026-08-26 the catalog reads from $79 a month for compounded semaglutide and from $159 for tirzepatide, against $99 and $169 in July. Same price at every dose is stated beside them, so titrating up does not raise the bill — but from is a floor and no ceiling or dose ladder is published anywhere. One question this record used to leave open is now answered on the site itself: yourEra says its clinician network is licensed in all 50 states, and repeats it in a badge and in its own founding story. The single price covers the telehealth visit, the medication, injection supplies, dose adjustments, unlimited messaging and shipping. Two things belong on your list before you pay. The refund policy stops refunds the moment the pharmacy begins preparing your order, whether or not it has shipped. And the Terms require you to have a device with a working video camera, which is the closest the site comes to telling you whether a live visit is part of this.

$99/mo semaglutide, $183/mo tirzepatide, all 50 states, a named physician personally reviewing every intake, and a real 5-7 day timeline — on a broader peptide platform where GLP-1 pricing is genuinely invisible unless you know to pull the page's own data bundle.

The lowest advertised flat rate on this roster — $79/mo semaglutide, $129/mo tirzepatide, fully async — but no stated time-to-first-dose, and the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held.

A flat $88/mo semaglutide and $157/mo tirzepatide with named medical groups and pharmacies behind it — the cheapest sticker in this batch, but a video visit is required and cancellation is by email, not a dashboard toggle.

Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.

For a working mother the appeal here is logistics as much as money: a fully online intake with no video call to schedule, all 50 states, and one flat charge per month that covers the visit, the plan, the medication and shipping — held at the same price whatever dose you end up on. Month to month that is $79 for compounded semaglutide and $109 for compounded tirzepatide; the $69 the homepage headlines under a countdown timer is the twelve-month tier, and $95 is its tirzepatide equivalent. Flat-by-dose is the part that actually protects a budget, because dose-priced providers routinely double between a starting and a maintenance dose. Two things to weigh against that. The off-ramp is narrow: subscriptions auto-renew, canceling means emailing care@leanmeds.com at least 48 hours before the processing date, and the order stops being refundable the moment you submit the medical intake. And the operator named throughout its own Terms — Trinity HealthCare Supply, LLC — is the company FDA wrote to on 8 June 2026 under its other brand, altRx, for labeling compounded vials with its own name when it was not the compounder and for calling compounded GLP-1s 'clinically proven.' That letter concerns altrx.com, not this site, but it is the same legal entity at the same Miami suite, and no pharmacy or clinician is named here either.

Flat at every dose - $99 semaglutide, $134 tirzepatide, all fifty states - which makes the annual math trivial. The site never names its operating company.

An all-inclusive $89/mo semaglutide program, LegitScript-certified and licensed in all 50 states — undercut by a homepage that advertises a different $99 first-month figure for the same product, and a tirzepatide option that's listed but never separately priced.

A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, and both prices are 'From' starting prices rather than a guaranteed working-dose rate.